Lincoln Pharmaceuticals reports Net Profit of Rs. 82.44 crore

Lincoln Pharmaceuticals Limited, one of India's leading healthcare companies has reported a standalone net profit of Rs. 82.44 crore for the FY25 ended March 2025 as against net profit of Rs. 93.37 crore FY24.

Delhi Govt Issues Advisory to Hospitals Amid Rise in COVID Cases

Due to the recent increase in COVID-19 cases, the Delhi government has issued advisory commending hospitals to raise preparedness,

Alembic Gets USFDA Approval for generic high blood pressure treatment drug

Alembic Pharmaceuticals has received final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Amlodipine and Atorvastatin Tablets USP...

Indoco Gets US FDA Nod for Allopurinol 200 mg Tablets

Indoco Remedies Ltd., a research focused pharmaceutical company, has received final approval from the US Food and drug Administration

Zydus to Launch Single Pen for Adjustable Semaglutide Doses

Zydus Lifesciences is developing a new semaglutide formulation for diabetes and obesity, two rapidly growing chronic conditions that are becoming increasingly debilitating. Rather than requiring patients to...

Gujarat Set to Approve Surat Drug Lab, Says FDCA Chief

Dr. Hemant G. Koshia, Commissioner of the Food and Drug Control Administration (FDCA) stated that the Gujarat government is in the final stage of approving a high-tech drug testing laboratory in Surat.

FDA Advisers Urge COVID Shots to Target JN.1 Variant Strains

A panel of advisers to the U.S. Food and Drug Administration (FDA) unanimously recommended that COVID-19 vaccines for the 2025–26 season target updated strains of the JN.1 variant, and particularly...

NIH Unveils Biomarker Score to Track Ultra-Processed Food Intake

Researchers at the National Institutes of Health (NIH) have identified distinct patterns of blood and urine metabolites that can objectively measure a person’s intake of ultra-processed foods. Published...

Bayer Tests GIRK4 Inhibitor in Phase I Study for AFib Care

Bayer has initiated a Phase I clinical trial for BAY 3670549, a first-in-class, highly selective G-protein-coupled inwardly rectifying potassium channel 4 (GIRK4) inhibitor, targeting atrial fibrillation (AFib)...

Indian MedTech Champions Circular Economy with Biodegradable Medical Products

According to Anish Bafna, CEO and Managing Director of Healthium Medtech, sustainability is growing a vital factor in global healthcare finding, especially across the US and Europe.

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.